Taken together, these data suggest that the lower than expected ERα degradation observed in vivo was not due to poor plasma exposure and a subsequent lack of ERα binding, since we still observed reduced PGR expression and tumour growth inhibition statistically equivalent to that achieved with 10 mg/kg AZD9833. This evidence concerns the gene ESR1 and neoplasm.